Search by First Name and/or Last Name. Results are displayed in descending publication year and then sorted ascending by the reference field. Need to submit a publication reference?
Name: Suzanne Schindler
Year: 2023
Reference:
Barthélemy NR, Saef B, Li Y, Gordon BA, He Y, Horie K, Stomrud E, Salvadó G, Janelidze S, Sato C, Ovod V, Henson RL, Fagan AM, Benzinger TLS, Xiong C, Morris JC, Hansson O, Bateman RJ, Schindler SE. CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease. Nature Aging. 2023. 1-11.
Name: Suzanne Schindler
Year: 2023
Reference:
Bayat S, Roe CM, Schindler S, Murphy SA, Doherty JM, Johnson AM, Walker A, Ances BM, Morris JC, Babulal GM. Everyday Driving and Plasma Biomarkers in Alzheimer’s Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit. J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221268. Epub ahead of print. PMID: 36938737.
Name: Susan Stark
Year: 2023
Reference:
Bollinger RM, Gabel M, Coble DW, Chen SW, Keleman A, Doralus J, Chin E, Lingler JH, Grill JD, Stark SL, Edwards DF. Retention of study partners in longitudinal studies of Alzheimer disease. Submitted to Journal of Alzheimer’s Disease
Name: Rebecca Bollinger
Year: 2023
Reference:
Bollinger RM, Gabel M, Coble DW, et al. Retention of Study Partners in Longitudinal Studies of Alzheimer Disease. Journal of Alzheimer’s Disease 2023; 94(1):189-199. DOI: 10.3233/jad-230079. PMID: 37212114.
Name: Suzanne Schindler
Year: 2023
Reference:
Bradley J, Gorijala P, Schindler SE, Sung YJ, Ances B, Neuroimaging Initiative The Human Connectome Project TAD, Fernandez MV, Cruchaga C. Genetic architecture of plasma Alzheimer disease biomarkers. Hum Mol Genet. 2023 May 19:ddad087. doi: 10.1093/hmg/ddad087. Epub ahead of print. PMID: 37208024.
Name: Suzanne Schindler
Year: 2023
Reference:
Brand AL, Lawler PE, Bollinger JG, Li Y, Schindler SE, Li M, Lopez S, Ovod V, Nakamura A, Shaw LM, Zetterberg H, Hansson O, Bateman RJ. The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review. Alzheimers Res Ther. 2022 Dec 27;14(1):195. doi: 10.1186/s13195-022-01117-1. PMID: 36575454; PMCID: PMC9793600.
Name: Suzanne Schindler
Year: 2023
Reference:
Chen CD, Ponisio MR, Lang JA, Flores S, Schindler SE, Fagan AM, Morris JC, Benzinger TLS. Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment. J Alzheimers Dis. 2023;93(2):765-777. doi: 10.3233/JAD-230032. PMID: 37092225; PMCID: PMC10200228.
Name: Suzanne Schindler
Year: 2023
Reference:
Cooley SA, Nelson B, Boerwinkle A, Yarasheski KE, Kirmess KM, Meyer MR, Schindler SE, Morris JC, Fagan A, Ances BM, O’Halloran J. Plasma Aβ42/Aβ40 ratios are not reduced in older people living with HIV. Clin Infect Dis. 2023 Jan 5:ciad001. doi: 10.1093/cid/ciad001. Epub ahead of print. PMID: 36610788.
Name: Suzanne Schindler
Year: 2023
Reference:
Cooley SA, Nelson B, Boerwinkle A, Yarasheski KE, Kirmess KM, Meyer MR, Schindler SE, Morris JC, Fagan A, Ances BM, O’Halloran JA. Plasma Aβ42/Aβ40 Ratios in Older People With Human Immunodeficiency Virus. Clin Infect Dis. 2023 May 24;76(10):1776-1783. doi: 10.1093/cid/ciad001. PMID: 36610788; PMCID: PMC10209437.
Name: Suzanne Schindler
Year: 2023
Reference:
Doherty JM, Murphy SA, Bayat S, Wisch JK, Johnson AM, Walker A, Schindler SE, Ances BM, Morris JC, Babulal GM. Adverse driving behaviors increase over time as a function of preclinical Alzheimer’s disease biomarkers. Alzheimers Dement. 2023 May;19(5):2014-2023. doi: 10.1002/alz.12852. Epub 2022 Nov 23. PMID: 36419201; PMCID: PMC10182221.
Name: Suzanne Schindler
Year: 2023
Reference:
Ferreiro AL, Choi J, Ryou J, Newcomer EP, Thompson R, Bollinger RM, Hall-Moore C, Ndao IM, Sax L, Benzinger TLS, Stark SL, Holtzman DM, Fagan AM, Schindler SE, Cruchaga C, Butt OH, Morris JC, Tarr PI, Ances BM, Dantas G. Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease. Sci Transl Med. 2023 Jun 14;15(700):eabo2984. doi: 10.1126/scitranslmed.abo2984. Epub 2023 Jun 14. PMID: 37315112.
Name: Suzanne Schindler
Year: 2023
Reference:
Hampel H, Hu Y, Cummings J, Mattke S, Iwatsubo T, Nakamura A, Vellas B, O’Bryant S, Shaw LM, Cho M, Batrla R, Vergallo A, Blennow K, Dage J, Schindler SE. Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape. Neuron. 2023 Jun 5:S0896-6273(23)00390-2. doi: 10.1016/j.neuron.2023.05.017. Epub ahead of print. PMID: 37295421.
Name: Susan Stark
Year: 2023
Reference:
Keleman AA, Chang CH, Bollinger RM, Lingler JH, Gabel M, Stark SL. Psychometric evaluation of the Perceived Research Burden Assessment (PeRBA) in longitudinal studies of Alzheimer disease using rasch analysis. Alzheimer Disease & Associated Disorders 2023;37(1):28-34.
Name: Susan Stark
Year: 2023
Reference:
Keleman AA, Nicosia J, Bollinger RM, Wisch, Hassesnstab J, Morris JC, Ances BM, Balota DA, Stark SL. It’s the body, not the brain: Precipitating mechanisms of falls in preclinical Alzheimer disease. Submitted to Journal of Alzheimer’s Disease Reports.
Name: Suzanne Schindler
Year: 2023
Reference:
Lawler PE, Bollinger JG, Schindler SE, Hodge CR, Iglesias NJ, Krishnan V, Coulton JB, Li Y, Holtzman DM, Bateman RJ. Apolipoprotein E O-glycosylation is associated with amyloid plaques and APOE genotype. Anal Biochem. 2023 Jul 1;672:115156. doi: 10.1016/j.ab.2023.115156. Epub 2023 Apr 16. PMID: 37072097.
Name: Suzanne Schindler
Year: 2023
Reference:
Li M, Li Y, Schindler SE, Yen D, Sutcliffe S, Babulal GM, Benzinger TLS, Lenze EJ, Bateman RJ. Design and feasibility of an Alzheimer’s disease blood test study in a diverse community-based population. Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13125. Epub ahead of print. PMID: 37204806.
Name: Suzanne Schindler
Year: 2023
Reference:
Oh IY, Schindler SE, Ghoshal N, Lai AM, Payne PRO, Gupta A. Extraction of clinical phenotypes for Alzheimer’s disease dementia from clinical notes using natural language processing. JAMIA Open. 2023 Feb 24;6(1):ooad014. doi: 10.1093/jamiaopen/ooad014. PMID: 36844369; PMCID: PMC9952043.
Name: Suzanne Schindler
Year: 2023
Reference:
Schindler SE, Atri A. The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer’s disease diagnostic revolution. Nature Aging. In press.
Name: Suzanne Schindler
Year: 2023
Reference:
Sung YJ, Yang C, Norton J, Johnson M, Fagan A, Bateman RJ, Perrin RJ, Morris JC, Farlow MR, Chhatwal JP, Schofield PR, Chui H, Wang F, Novotny B, Eteleeb A, Karch C, Schindler SE, Rhinn H, Johnson ECB, Oh HS, Rutledge JE, Dammer EB, Seyfried NT, Wyss-Coray T, Harari O, Cruchaga C. Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer’s disease. Sci Transl Med. 2023 Jul 5;15(703):eabq5923. doi: 10.1126/scitranslmed.abq5923. Epub 2023 Jul 5. PMID: 37406134.
Name: Suzanne Schindler
Year: 2023
Reference:
Wisch JK, Gordon BA, Boerwinkle AH, Luckett PH, Bollinger JG, Ovod V, Li Y, Henson RL, West T, Meyer MR, Kirmess KM, Benzinger TLS, Fagan AM, Morris JC, Bateman RJ, Ances BM, Schindler SE. Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40. Alzheimers Dement (Amst). 2023 Mar 2;15(1):e12405. doi: 10.1002/dad2.12405. PMID: 36874595; PMCID: PMC9980305.
Name: Andrew Aschenbrenner
Year: 2022
Reference:
Aschenbrenner AJ, Li Y, Henson RL, Volluz K, Hassenstab J, Verghese P, West T, Meyer MR, Kirmess KM, Fagan AM, Xiong C, Holtzman D, Morris JC, Bateman RJ, Schindler SE. Comparison of plasma and CSF biomarkers in predicting cognitive decline. Ann Clin Transl Neurol. 2022 Oct 2. doi: 10.1002/acn3.51670. Epub ahead of print. PMID: 36183195.
Format:
Name: Suzanne Schindler
Year: 2022
Reference:
Aschenbrenner AJ, Li Y, Henson RL, Volluz K, Hassenstab J, Verghese P, West T, Meyer MR, Kirmess KM, Fagan AM, Xiong C, Holtzman D, Morris JC, Bateman RJ, Schindler SE. Comparison of plasma and CSF biomarkers in predicting cognitive decline. Ann Clin Transl Neurol. 2022 Oct 2. PMID: 36183195.
Name: Andrew Aschenbrenner
Year: 2022
Reference:
Aschenbrenner AJ, Murphy SA, Doherty JM, Johnson AM, Bayat S, Walker A, Peña Y, Hassenstab J, Morris JC, Babulal GM. Neuropsychological correlates of changes in driving behavior among clinically healthy older adults. J Gerontol B Psychol Sci Soc Sci. 2022 Jul 23:gbac101. doi: 10.1093/geronb/gbac101. Epub ahead of print. PMID: 35869666.
Format:
Name: Suzanne Schindler
Year: 2022
Reference:
Brand AL, Lawler PE, Bollinger JG, Li Y, Schindler SE, Li M, Lopez S, Ovod V, Nakamura A, Shaw LM, Zetterberg H, Hansson O, Bateman RJ. The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review. Alzheimers Res Ther. 2022 Dec 27;14(1):195. doi: 10.1186/s13195-022-01117-1. PMID: 36575454; PMCID: PMC9793600.
Name: Anne Fagan
Year: 2022
Reference:
Casaletto KB, Kornack J, Paolillo EW, Rojas JC, VandeBunte A, Staffaroni AS, Lee S, Heuer H, Forsberg L, Ramos EM, Miller BL, Kramer JH, Yaffe K, Petrucelli L, Boxer A, Boeve B, Gendron TF, Rosen H; ALLFTD Consortium. Association of Physical Activity With Neurofilament Light Chain Trajectories in Autosomal Dominant Frontotemporal Lobar Degeneration Variant Carriers. JAMA Neurol. 2022 Nov 14:e224178. doi: 10.1001/jamaneurol.2022.4178. Epub ahead of print. PMID: 36374516; PMCID: PMC9664369.